US FDA Begins Building Pharma Industry Activity Prediction Tool

Algorithms are intended to help predict incoming workload, which will be used to help set user fees.

Close-up Of A Robot's Hand Predicting Future With Crystal Ball - Image
Preliminary results show INDs with End-of-Phase II meetings and other characteristics within a certain time period could become an NDA or BLA in 18 months. • Source: Shutterstock

To improve hiring and user fee calculations, the US Food and Drug Administration is attempting to predict drug development activity for the entire pharmaceutical industry.

The models, which employ internal FDA data, as well as information from clinicaltrials

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA

More from Agency Leadership